Summary
We used existing methods of transforming bacterial cells with a given plasmid in order to confer bacteria with
the ability to grow on a carbon source atypical of that species. In order to later assess whether or not both
the transformation and the plasmid design itself were successful, we ran control experiments that verified the
lack of certain sugar dehydrogenase pathways in E. Coli or P. Putida. For these experiments and all experiments
moving forward, the carbon sources used in our analyses were glucose, sucrose, ribitol, and D-arabitol. Given
these initial experiments, we moved forward with isolating the individual pathways that allowed our bacteria to
grow on their carbon source of choice and purified these parts.
Isolation and purification of these pathways allowed us to then amplify the corresponding parts such that we
could combine them into a plasmid of our design. Using Gibson HiFi assembly enzymes, these plasmids were
generated before being transformed into the appropriate bacteria via heat shock methods. Following this,
sequencing was used in order to determine whether or not our design had been properly incorporated into the
bacteria’s plasmid.
Once the cells were verified to have been successfully transformed, we moved forward in our experiment to assess
the bacteria’s responses to plasmid uptake in terms of whether or not the necessary enzymes would be produced.
In order to do so, we cultured the various transformed bacteria on those carbon sources on which they were not
initially able to grow to determine the extent to which the plasmid conferred to these bacteria the ability to
produce previously not present sugar dehydrogenase proteins. To test these newfound characteristics, time of
transformation, the concentration of the respective inducers, and concentration of sugar in the media were
varied and the results were observed.
Project Achievements
Successful Results
Over the course of the experiment we were successfully able to:
• Establish negative controls for both E. Coli and P. Putida
-
• Amplify parts isolated from the bacteria (origin of replication, a regulator of enzyme production, antibiotic resistance, respective sugar pathway)
-
• Use gel electrophoresis in order to verify the presence of the correct amplified parts (see Figure 13)
-
• Produce these plasmids: pFLtAb5, pFCiAb5, pFLtSc5, pFCiRi5, pFLtRi5 (see Figure 14)
-
• Verify the sequence of these plasmids using sequencing programs (as seen in the image above)
-
• Incorporate the aforementioned plasmids into P. Putida or E. Coli using heat shock or electroshock transformation
-
• Observe the growth of these transformed bacteria
Figure 1 - Establishing growth of P. Putida provided known usable carbon source (glucose)
Figure 2 - Establishing growth of E. Coli provided known usable carbon source (glucose)
Figure 3 - Control establishing no growth of P. Putida provided no usable carbon source
Figure 4 - Control establishing no growth of E. Coli provided no usable carbon source
Figure 5 - Establishing natural growth of P. Putida provided experimental carbon source (Arabitol)
Figure 6 - Establishing natural growth of E. Coli provided experimental carbon source (Arabitol)
Figure 7 - Establishing natural growth of P. Putida provided experimental carbon source (Ribitol)
Figure 8 - Establishing natural growth of E. Coli provided experimental carbon source (Ribitol)
Figure 9 - Establishing natural growth of P. Putida provided experimental carbon source (Sucrose)
Figure 10 - Establishing natural growth of E. Coli provided experimental carbon source (Sucrose)
Glucose | Arabitol | Ribitol | No sugar | Sucrose | |
---|---|---|---|---|---|
E. Coli | 18 × 107 colonies/mL | 30 × 107 colonies/mL | 30 × 107 colonies/mL | 30 × 107 colonies/mL | 20 × 107 colonies/mL |
P. Putida | 29 × 107 colonies/mL | 31 × 107 colonies/mL | 50 × 107 colonies/mL | 27 × 107 colonies/mL | 48 × 107 colonies/mL |
Figure 11 - Table establishes colony counts for baseline growth on control and on each type of provided sugar.
Note: Although colony counts might be similar between glucose and other three experimental carbon sources,
colony morphology is much clearer in glucose than the minute pinpoints observed with other sugars.
Figure 12 - Electrophoresis gel depicting verification of ribitol part of pFLtRi5 plasmid. The first band
(first from left) is a ladder dye used to delineate size of parts in 0.5kb increments. The second band (second
from left) was segmented using a forward primer in front of the respective regulator part (Ltet02) and reverse
primer internal to ribitol part at 1.5kb. The third band (third from left) depicts the entire ribitol metabolic
pathway as amplified through PCR at 2.5kb.
Figure 13 - Example of contamination often encountered over the course of experimentation. Spotted dilutions of
various plasmids on their respective sugars demonstrated highly dense growth among the supposedly least
concentrated spots (bottom right of both plates at bottom of image). When each contamination site was struck
onto plates, colony morphology was similar and not that of expected E. Coli (plate at top/middle of image).
Figure 14 - The sequenced pFLtRi5 plasmid designed by UFlorida iGEM 2021
Unsuccessful Results
Prior to optimizing transformation efficiency, it was necessary to establish solely transformed cells’
utilization of respective sugars to colonize. Initial experimentation appeared promising as transformed growth
occurred; however, its inconsistency even among sugars proved it ultimately inconclusive. In an effort to
establish that introduction of our plasmid allowed for selective growth, we attempted to control for numerous
factors that might have confounded our results.
There were several factors we considered that might have potentially inhibited the success of our sugar
selection. The first of these cases was the phase of the parent colony. Initially, whenever we subcultured from
the parent colony which we had already found and proven to have successfully taken up our sugar plasmid, we
would subculture and immediately add the respective inducer for either the Ltet or Cin regulator and begin an
experiment. We hypothesized the issue with this being that the parent colony, having already grown, existed in a
stationary growth phase where minimal further colony growth may be observed and biochemical processes are
stabilized to that required for continued survival. Given a new metabolic enzyme to produce may have either been
downregulated due to the importance of other factors necessary towards survival and thus enzyme production
occurring at a very slow rate or rather not enough necessary cellular machinery already present to produce the
enzyme due to high levels during growth being depleted. To address this issue, we performed an experiment in
which we took two subcultures from the same parent colony. One subculture, our control, was immediately treated
with the appropriate inducer; the other subculture was again quickly subcultured to obtain a colony in
exponential phase which was only then treated with the respective inducer. While the stationary phase may have
inhibited enzyme production, we hypothesized that the addition of an inducer during an exponential phase of
growth would allow for a greater availability of cellular resources and machinery to be dedicated towards
enzymatic production. Moreover, the exponential phase subculture had more time to produce the desired sugar
enzymes.
Rather than the phase of growth when conducting an experiment, another variable we sought to regulate was
whether the concentration of the respective inducer influenced the amount of enzyme produced. There are two
important implications regarding the effect of the inducer unto the regulator. With too little induced
production of the enzyme, the cell may not be able to produce enough of the enzyme to metabolize the respective
sugar and thus will die. However, too much of the enzyme produced might draw cellular resources and machinery
otherwise vital to growth and survival, likewise leading to cellular death. In order to account for both these
possibilities, we conducted an experiment varying our inducer concentration from that we regularly used to those
both lower and higher amounts. No colonies grew on the respective sugar regardless of inducer concentration.
With neither the growth phase nor inducer concentration ultimately being the cause for why our transformed
plasmids were yet unable to consistently grow on their respective sugars, we next turned towards the
concentration of the sugars. Because cells would only be able to survive if able to produce enough of the
respective enzymes to metabolize the provided sugar, the concentration present could have impacted cell
survival. Too little sugar might yield not enough of an energy source to power other integral cellular activity
and likewise limit growth potential whilst ample sugar should theoretically allow for much greater growth
potential than what had been observed with the concentration provided through previous experiments. In order to
test the significance of sugar concentration on our transformed cells’ survival, we set up a liquid culture
experiment. To test the effect of sugar concentration, a single one of our plasmids were considered at a time.
Within liquid media, five various sugar concentrations were suspended and then inoculated with a subculture. One
set of five liquid cultures contained transformed cells that retained the appropriate enzyme for the suspended
sugar as the other set of five liquid cultures were inoculated with transformed cells retaining a different
plasmid for another sugar not present. As such, we were able to use our successfully transformed cells to
evaluate survivability. Ultimately, however, equivalent growth was observed in both the positive and negative
controls at lower sugar concentrations and cell debris in both the positive and negative at higher
concentrations. A potential cause of this unexpected result at higher sugar concentrations could have been that
cellular resources were exhausted in producing the desired enzyme in the presence of greater energy supply that
other necessary cell functions were inhibited or downregulated per the result of the present enzymatic activity.
An important factor was discovered later in our lab work that resulted in our needing to repeat experiments to
retain validity in our results. When exploring potential factors that might be causing our transformed cells to
not display expected select growth, we discovered the supplementary strain of E. Coli used was an auxotroph. As
a result of the strain utilized having been engineered to better be able to take up and retain genetic material,
certain experimentally designed strains are known to necessitate something not needed in the wild type. In our
case, we discovered that it was necessary to supplement amino acid Leucine in experimental design in order for
the cell to perform a variety of vital functions. This alteration in design was incorporated into all subsequent
experiments in addition to asserting prior experimental results.
Finally, as growth phase, inducer influence, and sugar concentration were proven to not be primarily responsible
for the lack of expected select growth, we decided to further verify enzymatic production. With evidence
supporting the accuracy of our new engineered genetic part and inability to observe the expected growth of
transformed cells, we instead looked to any potential issue in the process of enzyme production itself. We were
able to assess the production of the desired enzymes coded for by our plasmids through an assay analysis. In
opting to evaluate the presence of coded-for dehydrogenase enzymes, we were able to take advantage of the
NAD/NADH cofactor system commonly present in a variety of metabolic systems through various lineages. By lysing
varying amounts of our transformed cells and immediately screening for a change in ratio of NAD:NADH present
over time, we were able to evaluate for the expected trend of greater transformed cellular lysate equating to
greater changes of the NAD:NADH ratio in the observed time interval. Nevertheless, we found that compared to a
control in which no cell lysate and thus no dehydrogenase enzyme present to hasten the NAD:NADH conversion, the
observed varying concentration did not prove any conclusive association that evidenced greater dehydrogenase
present in lysate resulting in greater changes in the cofactor over time.
Although we were unable to demonstrate sugar introduction as an alternative selectable marker, we were able to
successfully engineer and introduce a novel plasmid with the code for transferable sugar-metabolizing pathways
to Pseudomonas.putida and Escherichia.coli. Numerous complications exist in the manifestation of full
transference of a metabolic pathway. Many metabolites serve as complex intermediates within several systemic
pathways that play integral roles in cell function. Introducing mechanisms to metabolize new substances likely
incur innumerable opportunities to confound a natural pathway integral to the survival of a cell. Even with
fully analyzing the biochemical interactions responsible for metagenomic-derived processes, there are always
more details to be yet discovered to truly uncover why our system was unable to materialize. Moreover, there
additionally could have been complications arising from the aspect of synthetic biology. As we commonly used
transformed cells of one sugar as the positive control in an experiment meant to test another sugar, it may be
that the respective inducer added to stimulate the included regulator might have potential crossover with common
promoters among the other control. Finally, an exhaustion of cellular resources necessary to construct the coded
enzymes may have had compounding effects on those available for other cell functions as well. Further testing is
needed to establish a basis of consistency in expected selection prior to systemic optimization and judging
efficacy as a potential replacement for alternative selectable markers to traditional antibiotics; however, we
considered numerous variables integral to and were able to successfully produce the genetic parts to enable the
eventual creation of such a system.
Design considerations for future teams interested in markers:
Team UFLORIDA understands the importance of collaboration and building upon previous work. We hope our project can provide the educational means to inspire and help future teams continue the synthetic biology aspects in alternative selection markers. We were able to work on the wet lab aspect of this project through the summer. We understand that science takes time and with this opportunity, we have provided a list of controls and additional work we think future teams should consider for further applications:
-
1. Set up additional controls: If your plasmid does not seem to work, see if you can order the fully assembled plasmid from a third party company and test it on your target bacteria. This will help you further narrow down whether there are issues with the reading frame of your circuit or any other error malfunctions that can arise from plasmid assembly.
- 2. Design a plasmid that has a localization signal peptide like the MalE(BBa_K3114001) secretion tag. This is a 26 amino acid sequence that is fused to the N-region of a protein. This tag can target our desired CDS and export it via the Sec secretion pathway to the periplasmic space. The project could also test the viability of different tags as extra procedures using the igem repository signal peptides for recombinant protein expression in our bacteria. This can help rule out whether our proteins would work if they can be exported to the periplasmic space. It seems that our CDS proteins are aggregating in the cytosolic space and as such trying different signal peptides with our system can result in further troubleshooting.
References
Becker, N. A., Peters, J. P., Lionberger, T. A., & Maher, L. J. (2012). Mechanism of promoter repression by LAC
repressor–DNA loops. Nucleic Acids Research, 41(1), 156–166. https://doi.org/10.1093/nar/gks1011
Debowski, A. W., Verbrugghe, P., Sehnal, M., Marshall, B. J., & Benghezal, M. (2013). Development of a
tetracycline-inducible gene expression system for the study of helicobacter pylori pathogenesis. Applied and
Environmental Microbiology, 79(23), 7351–7359. https://doi.org/10.1128/aem.02701-13
Kluge, J., Terfehr, D., & Kück, U. (2018). Inducible promoters and functional genomic approaches for the genetic
engineering of filamentous fungi. Applied Microbiology and Biotechnology, 102(15), 6357–6372.
https://doi.org/10.1007/s00253-018-9115-1
Lecturio. (2020, October 2). Biochemical pathways: The Pentose Phosphate Pathway: Lecturio. The Lecturio Online
Medical Library. Retrieved October 20, 2021, from https://www.lecturio.com/magazine/pentose-phosphate-pathway/.
Meyer, A. J., Segall-Shapiro, T. H., Glassey, E., Zhang, J., & Voigt, C. A. (2018). Escherichia coli
“marionette” strains with 12 highly optimized small-molecule sensors. Nature Chemical Biology, 15(2), 196–204.
https://doi.org/10.1038/s41589-018-0168-3
Pathway: D-arabitol degradation. MetaCyc D-arabitol degradation. (1998, August 21). Retrieved October 20, 2021,
from https://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=DARABITOLUTIL-PWY.
Pathway: ribitol degradatio. MetaCyc ribitol degradation. (1998, August 21). Retrieved October 20, 2021, from
https://metacyc.org/META/NEW-IMAGE?type=PATHWAY&object=RIBITOLUTIL-PWY.
Pathway: sucrose degradation VII (sucrose 3-dehydrogenase). MetaCyc sucrose degradation VII (sucrose
3-dehydrogenase). (1998, September 9). Retrieved October 20, 2021, from
https://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=SUCROSEUTIL2-PWY.
Scholz, P., Haring, V., Wittmann-Liebold, B., Ashman, K., Bagdasarian, M., & Scherzinger, E. (1989). Complete
nucleotide sequence and gene organization of the broad-host-range plasmid RSF1010. Gene, 75(2), 271–288.
https://doi.org/10.1016/0378-1119(89)90273-4
Schuster, L. A., & Reisch, C. R. (2021). A plasmid toolbox for controlled gene expression across the
Proteobacteria. Nucleic Acids Research, 49(12), 7189–7202. https://doi.org/10.1093/nar/gkab496
Sequence analyzer: PFCIKM7 sequencing result. Addgene pFCiKm7 Sequencing Result - Sequence Analyzer. (n.d.).
Retrieved October 20, 2021, from https://www.addgene.org/browse/sequence/332932/.
Sequence analyzer: PFLTR5 sequencing result. Addgene pFLtR5 Sequencing Result - Sequence Analyzer. (n.d.).
Retrieved October 20, 2021, from https://www.addgene.org/browse/sequence/332638/.
Shin, J., Zhang, S., Der, B. S., Nielsen, A. A. K., & Voigt, C. A. (2020). Programming escherichia coli to
function as a digital display. Molecular Systems Biology, 16(3). https://doi.org/10.15252/msb.20199401
Wilkinson, A., Danino, V., Wisniewski-Dyé F., Lithgow, J. K., & Downie, J. A. (2002). N -acyl-homoserine
lactone inhibition of rhizobial growth is mediated by two quorum-sensing genes that regulate plasmid transfer.
Journal of Bacteriology, 184(16), 4510–4519. https://doi.org/10.1128/jb.184.16.4510-4519.2002